The effect of Lavender planet in the treatment on tremor of Multipl Sclerosis patients

INTERVENTION: Control group: placebo, oral capsule, Once a day for 8 weeks, made by Barijessence Pharmaceutical Factory Intervention 1: Control group: placebo, oral capsule, Once a day for 8 weeks, made by Barijessence Pharmaceutical Factory. Intervention 2: Intervention group: Iranian Lavender oil, 80 mg oral capsule, Once a day for 8 weeks, made by Barijessence Pharmaceutical Factory. Intervention group: Iranian Lavender oil, 80 mg oral capsule, Once a day for 8 weeks, made by Barijessence Pharmaceutical Factory Placebo Treatment ‐ Drugs CONDITION: G00‐G99 Multiple Sclerosis. ; G35 PRIMARY OUTCOME: Tremor. Timepoint: Questionnair :before the intervention, after four weeks of intervention and after the intervention / Tremor measuring machine: before the intervention and after the intervention. Method of measurement: Questionnair:Tremor part from MDS‐UDPRS/ Tremor measuring machine(Motion Capture System). SECONDARY OUTCOME: Drug Side effects. Timepoint: Four weeks after the intervention, after intervention. Method of measurement: Oral questions from patients. INCLUSION CRITERIA: Including criteria: 1:Having proven MS according to the clinical examination and medical history 2:EDSS rating between 2 to 5.5 3:Having constant and regular medical treatment in the past 4 weeks 4:Consent to use of alternative medicines 7 days before the start of intervention to the end of intervention 5:Not be in another study at the same time 6:Age 15 to 50 years Excluding criteria: 1:History of alcohol or drug dependence 2:pregnancy or Breastfeeding 3:Impaired renal and/or liver function 4:Treatment with steroids over a month before the start of the study 5:Having a neurological disease in addition to multiple sclerosis 6: Having Cardiovascular or Lung disease( such as Asthma) or Diabetes 7:Allergy to Lavender